Cover Image
市場調查報告書

Zhejiang Hisun Pharmaceutical Co., Ltd.的產品平台分析

Zhejiang Hisun Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 309672
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
Zhejiang Hisun Pharmaceutical Co., Ltd.的產品平台分析 Zhejiang Hisun Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
出版日期: 2014年07月31日 內容資訊: 英文 29 Pages
簡介

Zhejiang Hisun Pharmaceutical Co., Ltd.是總公司設立於中國的製藥企業,研究開發設備位於上海及北京。從事抗癌藥物,心血管用治療藥,抗菌藥,抗寄生蟲藥,內分泌控制劑,免疫抑制劑,抗憂鬱症藥等API的製造,原料藥製造及商品化。

本報告提供Zhejiang Hisun Pharmaceutical Co., Ltd.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Zhejiang Hisun Pharmaceutical Co., Ltd.的基本資料

  • Zhejiang Hisun Pharmaceutical Co., Ltd.概要
  • 主要資訊
  • 企業資料

Zhejiang Hisun Pharmaceutical Co., Ltd.:R&D概要

  • 主要的治療範圍

Zhejiang Hisun Pharmaceutical Co., Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Zhejiang Hisun Pharmaceutical Co., Ltd.:開發中產品概況

  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Zhejiang Hisun Pharmaceutical Co., Ltd.:藥物簡介

  • firtecan pegol
  • HS-25
  • CBLB-612

Zhejiang Hisun Pharmaceutical Co., Ltd.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Zhejiang Hisun Pharmaceutical Co., Ltd.:最新的開發平台資訊

Zhejiang Hisun Pharmaceutical Co., Ltd.:暫停開發的計劃

Zhejiang Hisun Pharmaceutical Co., Ltd.:企業理念

Zhejiang Hisun Pharmaceutical Co., Ltd.:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

目錄
Product Code: GMDHC05799CDB

Summary

Global Markets Direct's, 'Zhejiang Hisun Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Zhejiang Hisun Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Zhejiang Hisun Pharmaceutical Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Zhejiang Hisun Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Zhejiang Hisun Pharmaceutical Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Zhejiang Hisun Pharmaceutical Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate Zhejiang Hisun Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Zhejiang Hisun Pharmaceutical Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Zhejiang Hisun Pharmaceutical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Zhejiang Hisun Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Zhejiang Hisun Pharmaceutical Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Zhejiang Hisun Pharmaceutical Co., Ltd. Snapshot
    • Zhejiang Hisun Pharmaceutical Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline Products Glance
    • Zhejiang Hisun Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Zhejiang Hisun Pharmaceutical Co., Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Drug Profiles
    • firtecan pegol
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HS-25
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CBLB-612
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline Analysis
    • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline Products by Target
    • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration
    • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type
    • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Recent Pipeline Updates
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Dormant Projects
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Company Statement
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Zhejiang Hisun Pharmaceutical Co., Ltd., Key Information
  • Zhejiang Hisun Pharmaceutical Co., Ltd., Key Facts
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline by Indication, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Phase II, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Preclinical, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline by Target, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2014

List of Figures

  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline by Top 10 Target, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline by Top 10 Route of Administration, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline by Top 10 Molecule Type, 2014
  • Zhejiang Hisun Pharmaceutical Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top